bioRxiv preprint doi: https://doi.org/10.1101/316729; this version posted May 11, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Title: Regulation of the error-prone DNA polymerase polκ by oncogenic signaling and its contribution to drug resistance 1,2 3 4 5 Authors: Kelsey Temprine , Erin M Langdon , Krisha Mehta , Averill Clapp , Richard M White1* Affiliations: 1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. 2Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. 3University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA. 4Division of General Internal Medicine, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. 5University of Chicago, Chicago, IL 60637, USA. * Corresponding author. Email:
[email protected] One Sentence Summary: Cancer cells under stress from oncogene or mTOR inhibition dysregulate the error-prone DNA polymerase polk, which contributes to drug resistance in melanoma cells. 1 bioRxiv preprint doi: https://doi.org/10.1101/316729; this version posted May 11, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Mutations in the proofreading domains of the replicative DNA polymerases polδ and polε are associated with elevated mutation rates in cancer, but the roles of other DNA polymerases in tumorigenesis remain poorly understood.